How long does one box of Bosutinib last?

Bosutinib is an oral small molecule tyrosine kinase inhibitor. The duration and duration of treatment depend on the patient's specific condition, dosage regimen, and tolerance to the drug. The usual recommended dose of bosutinib for the treatment of chronic myelogenous leukemia (CML) is usually 400 to 500 mg once daily. Taking a box of 30 or 60 tablets as an example, most patients take it once a day, and a box of medicine can generally last for 1 to 2 months of treatment. However, actual medication times still need to be adjusted based on individual differences.

For initial users, doctors may reduce the dose appropriately based on the patient's liver and kidney function and the occurrence of adverse reactions; while for patients with stable conditions and good tolerance, the original dose may be maintained for a long time. Some overseas clinical practices have shown that if patients experience common side effects such as diarrhea, rash, fatigue, etc., they can temporarily stop taking the drug or reduce the dose to 300 mg per day and then continue using it, thereby extending the medication cycle. Bosutinib is a targeted drug that requires long-term medication to maintain efficacy. It is not recommended to interrupt or adjust the dose at will, otherwise the therapeutic effect may be affected. The medicine should be taken on time under the guidance of a doctor, and avoid eating with grapefruit-based foods to avoid affecting metabolism.

It is worth noting that the packaging specifications of bosutinib are slightly different in different countries or regions. For example, the European and Turkish versions are common60 tablets, while Indian generics are mostly 30 tablets, so the dosage cycle also changes accordingly. Generally speaking, a box of bosutinib can usually be taken for 30 to 60 days, and the specific treatment course needs to be flexibly adjusted according to individual response. During long-term treatment, regular monitoring of blood images, liver function and blood drug concentration can help doctors judge the efficacy and safety of the drug, thereby more accurately deciding whether to extend the course of treatment or adjust the dose.

Reference materials:https://go.drugbank.com/drugs/DB06616